Skip to main content
Erschienen in: Supportive Care in Cancer 7/2013

01.07.2013 | Original Article

Toward clinical care guidelines for supporting rehabilitative vaginal dilator use with women recovering from cervical cancer

verfasst von: Kimberley Cullen, Karen Fergus, Tracey DasGupta, Iwa Kong, Marg Fitch, Catherine Doyle, Lauran Adams

Erschienen in: Supportive Care in Cancer | Ausgabe 7/2013

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Building upon the findings of a recent qualitative investigation of women’s experiences with rehabilitative vaginal dilator use, the primary goal of this article is to outline a set of preliminary clinical care recommendations that health care professionals may draw upon in addressing women’s unique experiences with vaginal dilator use including their multifaceted struggles with the procedure, possibly enhancing adherence to this practice.

Methods

Ten women participated in in-depth interviews regarding their experiences with using the dilator as prescribed by their health care providers. Following the analysis of these interviews, members of the interdisciplinary research team met to review and discuss the development of clinical care recommendations stemming from these findings.

Results

Eight care recommendations aimed at addressing the concerns expressed by the women interviewed and at improving women’s overall experiences with rehabilitative dilator use emerged: (1) introduce the dilator in a light and straightforward manner; (2) enhance dilator accessibility; (3) introduce the vaginal dilator early on in treatment; (4) emphasize health maintenance over intercourse as a benefit of dilator use; (5) explore and acknowledge women’s values and views of sexuality; (6) increase awareness and sensitivity to emotional reactions; (7) enhance psychoeducational resources for supporting vaginal dilator use; and (8) ensure consistent institutional practice when introducing the dilator.

Conclusion

The clinical care recommendations proposed here reflect the various challenges women may encounter when using the vaginal dilator—which vary from practical to, for some, profoundly emotional—and are designed to better position health care providers to help women navigate these challenges.
Literatur
3.
Zurück zum Zitat Faithfull S, White I (2008) Delivering sensitive health care information: challenging the taboo of women’s sexual health after pelvic radiotherapy. Patient Educ Couns 71:228–233PubMedCrossRef Faithfull S, White I (2008) Delivering sensitive health care information: challenging the taboo of women’s sexual health after pelvic radiotherapy. Patient Educ Couns 71:228–233PubMedCrossRef
4.
Zurück zum Zitat Jeffries SA, Robinson JW, Craighead PS, Keats MR (2006) An effective group psychoeducational intervention for improving compliance with vaginal dilation: a randomized controlled trial. Int J Radiat Oncol 65:404–411CrossRef Jeffries SA, Robinson JW, Craighead PS, Keats MR (2006) An effective group psychoeducational intervention for improving compliance with vaginal dilation: a randomized controlled trial. Int J Radiat Oncol 65:404–411CrossRef
5.
Zurück zum Zitat Brand AH, Bull CA, Cakir B (2006) Vaginal stenosis in patients treated with radiotherapy for carcinoma of the cervix. Int J Gynecol Cancer 16:288–293PubMedCrossRef Brand AH, Bull CA, Cakir B (2006) Vaginal stenosis in patients treated with radiotherapy for carcinoma of the cervix. Int J Gynecol Cancer 16:288–293PubMedCrossRef
6.
Zurück zum Zitat Decruze SB, Guthrie D, Magnani R (1999) Prevention of vaginal stenosis in patients following vaginal brachytherapy. Clin Oncol 11:46–48CrossRef Decruze SB, Guthrie D, Magnani R (1999) Prevention of vaginal stenosis in patients following vaginal brachytherapy. Clin Oncol 11:46–48CrossRef
7.
Zurück zum Zitat Lancaster L (2004) Preventing vaginal stenosis after brachytherapy for gynaecological cancer: an overview of Australian practices. Eur J Oncol Nurs 8:30–39PubMedCrossRef Lancaster L (2004) Preventing vaginal stenosis after brachytherapy for gynaecological cancer: an overview of Australian practices. Eur J Oncol Nurs 8:30–39PubMedCrossRef
8.
Zurück zum Zitat Friedman LC, Abdallah R, Schluchter M, Panneerselvam A, Kunos CA (2011) Adherence to vaginal dilation following high dose rate brachytherapy for endometrial cancer. Int J Radiat Oncol 80:751–757CrossRef Friedman LC, Abdallah R, Schluchter M, Panneerselvam A, Kunos CA (2011) Adherence to vaginal dilation following high dose rate brachytherapy for endometrial cancer. Int J Radiat Oncol 80:751–757CrossRef
9.
Zurück zum Zitat Carter J, Sonoda Y, Chi DS, Raviv L, Abu-Rustum NR (2008) Radical trachelectomy for cervical cancer: postoperative physical and emotional adjustment concerns. Gynecol Oncol 111:151–157PubMedCrossRef Carter J, Sonoda Y, Chi DS, Raviv L, Abu-Rustum NR (2008) Radical trachelectomy for cervical cancer: postoperative physical and emotional adjustment concerns. Gynecol Oncol 111:151–157PubMedCrossRef
10.
Zurück zum Zitat Carter J, Goldrank D, Schover LR (2011) Simple strategies for vaginal health promotion in cancer survivors. J Sex Med 8:549–559PubMedCrossRef Carter J, Goldrank D, Schover LR (2011) Simple strategies for vaginal health promotion in cancer survivors. J Sex Med 8:549–559PubMedCrossRef
11.
Zurück zum Zitat Denton AS, Maher J (2003) Interventions for the physical aspects of sexual dysfunction in women following pelvic radiotherapy. Cochrane Database Syst Rev (1):CD003750 Denton AS, Maher J (2003) Interventions for the physical aspects of sexual dysfunction in women following pelvic radiotherapy. Cochrane Database Syst Rev (1):CD003750
12.
Zurück zum Zitat Miles T, Johnson N (2010) Vaginal dilator therapy for women receiving pelvic radiotherapy. Cochrane Database Syst Rev (9):CD007291 Miles T, Johnson N (2010) Vaginal dilator therapy for women receiving pelvic radiotherapy. Cochrane Database Syst Rev (9):CD007291
13.
Zurück zum Zitat Johnson N, Miles T, Cornes P (2010) Dilating the vagina to prevent damage from radiotherapy: systematic review of the literature. Bjog-Int J Obstet Gy 117:522–531CrossRef Johnson N, Miles T, Cornes P (2010) Dilating the vagina to prevent damage from radiotherapy: systematic review of the literature. Bjog-Int J Obstet Gy 117:522–531CrossRef
14.
Zurück zum Zitat Velaskar SM, Martha R, Mahantashetty U, Badakare JS, Shrivastava SK (2007) Use of indigenous vaginal dilator in radiation induced vaginal stenosis. Indian J Occup Ther 34:3–6 Velaskar SM, Martha R, Mahantashetty U, Badakare JS, Shrivastava SK (2007) Use of indigenous vaginal dilator in radiation induced vaginal stenosis. Indian J Occup Ther 34:3–6
15.
Zurück zum Zitat Jefferies H, Hoy S, McCahill R, Crichton A (2007) Guidelines on vaginal dilator use after pelvic radiotherapy. Nurs Times 103:28–29 Jefferies H, Hoy S, McCahill R, Crichton A (2007) Guidelines on vaginal dilator use after pelvic radiotherapy. Nurs Times 103:28–29
17.
Zurück zum Zitat White I, Faithfull S (2006) Vaginal dilation associated with pelvic radiotherapy: a UK survey of current practice. Int J Gynecol Cancer 16:1140–1146PubMedCrossRef White I, Faithfull S (2006) Vaginal dilation associated with pelvic radiotherapy: a UK survey of current practice. Int J Gynecol Cancer 16:1140–1146PubMedCrossRef
18.
Zurück zum Zitat Schover LR, Fife M, David M, Gershenson DM (1989) Sexual dysfunction and treatment for early stage cervical cancer. Cancer 63:204–212PubMedCrossRef Schover LR, Fife M, David M, Gershenson DM (1989) Sexual dysfunction and treatment for early stage cervical cancer. Cancer 63:204–212PubMedCrossRef
19.
Zurück zum Zitat Bruner DW, Lanciano R, Keegan M, Corn B, Martin E, Hanks GE (1993) Vaginal stenosis and sexual function following intracavitary radiation for the treatment of cervical and endometrial cancer. Int J Radiat Oncol 27:825–830CrossRef Bruner DW, Lanciano R, Keegan M, Corn B, Martin E, Hanks GE (1993) Vaginal stenosis and sexual function following intracavitary radiation for the treatment of cervical and endometrial cancer. Int J Radiat Oncol 27:825–830CrossRef
20.
Zurück zum Zitat Punt L (2011) Patient compliance with the use of vaginal dilators following pelvic radiotherapy for a gynecological cancer. J Radiother Pract 10:13–25 Punt L (2011) Patient compliance with the use of vaginal dilators following pelvic radiotherapy for a gynecological cancer. J Radiother Pract 10:13–25
21.
Zurück zum Zitat Stilos K, Doyle C, Daines P (2008) Addressing the sexual health needs of patients with gynecologic cancers. Clin J Oncol Nurs 12:457–463PubMedCrossRef Stilos K, Doyle C, Daines P (2008) Addressing the sexual health needs of patients with gynecologic cancers. Clin J Oncol Nurs 12:457–463PubMedCrossRef
22.
Zurück zum Zitat Katz A (2005) The sounds of silence: sexuality information for cancer patients. J Clin Oncol 23:238–241PubMedCrossRef Katz A (2005) The sounds of silence: sexuality information for cancer patients. J Clin Oncol 23:238–241PubMedCrossRef
23.
Zurück zum Zitat Cullen K, Fergus K, DasGupta T, Fitch M, Doyle C, Adams L (2012) From “sex toy” to intrusive imposition: a qualitative examination of women’s experiences with vaginal dilator use following treatment for gynecological cancer. J Sex Med 9:1162–1173PubMedCrossRef Cullen K, Fergus K, DasGupta T, Fitch M, Doyle C, Adams L (2012) From “sex toy” to intrusive imposition: a qualitative examination of women’s experiences with vaginal dilator use following treatment for gynecological cancer. J Sex Med 9:1162–1173PubMedCrossRef
24.
Zurück zum Zitat Glaser BG, Strauss A (1967) The discovery of grounded theory: strategies for qualitative research. Aldine, Chicago Glaser BG, Strauss A (1967) The discovery of grounded theory: strategies for qualitative research. Aldine, Chicago
25.
Zurück zum Zitat Juraskov I, Butow P, Robertson L, Sharpe L, McLeod C, Hacker N (2003) Post-treatment sexual adjustment following cervical and endometrial cancer: a qualitative insight. Psycho-Oncol 12:267–279CrossRef Juraskov I, Butow P, Robertson L, Sharpe L, McLeod C, Hacker N (2003) Post-treatment sexual adjustment following cervical and endometrial cancer: a qualitative insight. Psycho-Oncol 12:267–279CrossRef
26.
Zurück zum Zitat Guglietti CL, Rosen B, Murphy KJ, Laframboise S, Dodge J, Ferguson S, Katz J, Ritvo P (2010) Prevalence and predictors of posttraumatic stress in women undergoing an ovarian cancer investigation. Psychol Serv 7(4):266–74.24CrossRef Guglietti CL, Rosen B, Murphy KJ, Laframboise S, Dodge J, Ferguson S, Katz J, Ritvo P (2010) Prevalence and predictors of posttraumatic stress in women undergoing an ovarian cancer investigation. Psychol Serv 7(4):266–74.24CrossRef
27.
Zurück zum Zitat Urbaniec OA, Collins K, Denson LA, Whitford HS (2011) Gynecological cancer survivors: assessment of psychological distress and unmet supportive care needs. J Psychosoc Oncol 29(5):534–551PubMedCrossRef Urbaniec OA, Collins K, Denson LA, Whitford HS (2011) Gynecological cancer survivors: assessment of psychological distress and unmet supportive care needs. J Psychosoc Oncol 29(5):534–551PubMedCrossRef
Metadaten
Titel
Toward clinical care guidelines for supporting rehabilitative vaginal dilator use with women recovering from cervical cancer
verfasst von
Kimberley Cullen
Karen Fergus
Tracey DasGupta
Iwa Kong
Marg Fitch
Catherine Doyle
Lauran Adams
Publikationsdatum
01.07.2013
Verlag
Springer-Verlag
Erschienen in
Supportive Care in Cancer / Ausgabe 7/2013
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-013-1726-6

Weitere Artikel der Ausgabe 7/2013

Supportive Care in Cancer 7/2013 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.